5 Biggest Neuroscience Companies in the World

3. Merck & Co., Inc. (NYSE:MRK)

Market Cap as of January 07, 2023: $291.16 billion

Headquartered in New Jersey, United States, Merck & Co., Inc. (NYSE:MRK) is a global pharmaceutical company that develops, manufactures, and markets a range of prescription drugs, vaccines, and other healthcare products. The company’s pharmaceutical products are focused on therapeutic areas such as infections, cardiometabolic diseases, cancer, etc. The company’s immuno-oncology platform is expanding as a significant contributor to total sales in the cancer market. The pharmaceutical side of the neuroscience segment of the company is focused on developing treatments for neurological disorders such as early-stage and advanced Alzheimer’s, depression, and schizophrenia. In early 2021, Merck & Co., Inc. (NYSE:MRK) announced a three-year collaboration with the Transylvanian institute of technology (TINS) to research and improve their understanding of information processing in the human brain which will be the key to overcoming the current limitations of artificial intelligence technology.